Search Results 701-710 of 19867 for Hepatitis C

  1. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Mayo Clinic

    ... C, ROS1, or ALK kinase domain, respectively, without a concomitant ... hepatitis C virus (HCV) infections, as noted below: HIV positivity, only if ...

  2. Analytic Treatment Interruption (ATI) to Assess HIV Cure - Mayo Clinic

    Evidence of viral replication with Hepatitis C virus (HCV), together with evidence of any hepatic fibrosis or inflammation. Such patients should be offered ...

  3. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease..., Portal hypertension, Ascites, Alcoholic hepatitis. Show more areas of focus for Hugo E. Vargas ...

  4. Rheumatoid factor - Mayo Clinic

    C-reactive protein (CRP). Erythrocyte sedimentation rate (ESR, or sed rate) ... Chronic infections, such as viral hepatitis B and C. Inflammatory lung ...

  5. Safe Sleeping Space for Babies - Mayo Clinic News Network

    ... Hepatitis C. Related Articles. Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026 featured. Cancer. Mayo ...

  6. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

    - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. Patients with HCV infection who are currently on treatment ...

  7. Dtap, hepatitis b, poliovirus, and haemophilus b vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    Fever over 100.4 degrees F (38 degrees C). Less common. Prolonged crying lasting more than 3 hours. Rare. Bluish lips or skin; chills; confusion; dizziness ...

  8. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

    ... hepatitis C; patients must have negative testing for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) within 4 weeks prior to randomization ...

  9. Mayo Clinic Launches Whole Genome Breast Cancer Study

    Transmission Of Hepatitis C Infection To Patients · Pairing Patients With Mouse Avatars For Whole Genome Breast Cancer Study. Related Articles. Mayo Clinic ...

  10. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Have active hepatitis B or hepatitis C defined as: o HBV: hepatitis B ... hepatitis B core antibody (HBc Ab) positive subjects; o HCV: HCV ribonucleic ...